https://www.wsj.com/articles/instagram-reels-tiktok-meta-facebook-documents-11662991777
Reported Earlier, Autolus Therapeutics Presents Results From Pivotal Phase 2 FELIX Study In Adult r/r B-ALL At ASCO
76% of patients treated with obe-cel in the FELIX study achieved a response (CR/CRi), primary endpoint has been met based on previously communicated interim analysis
Potential best in class tolerability,